MUHD

COM:MUHDO

Muhdo

  • Privately Held

Company Overview

Metric
Company NameMuhdo23Rightangled
SymbolME
MSH IDCOM:MUHDOCOM:23ANDMECOM:RIGHTANGLED
MarketPRIVATESTOCKSPRIVATE
SectorHealthcare & Health ServicesHealthcareHealthcare & Health Services
IndustryMedical TechnologyMedical - Diagnostics & ResearchPharmacy
CountryGBUSGB
Stage
Employee Count560
Websitemuhdo.com23andme.comrightangled.com
LinkedInmuhdo23andmerightangled-limited
Founders

Market Metrics

Metric
Market Cap225.52M
Enterprise Value
Monthly Web Traffic28.49K6.55M
Web Traffic Growth14.23-0.06
Valuation
Raised Capital

Financial Performance

Metric
Revenue219.64M
Revenue (LTM)
Revenue (NTM)
Gross Profit99.38M
EBITDA-291.88M
Operating Income-321.36M
Net Income-666.70M
EPS-1.40
Diluted EPS-1.40
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.45
Operating Profit Margin-2.17
EBITDA Margin-1.33
Net Profit Margin-2.10
Return on Equity-0.87
Return on Assets-0.86
Return on Capital Employed-1.16

Valuation Multiples

Metric
P/E Ratio-0.93
P/B Ratio0.50
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio13.37
EV Multiple-3.85

Operational Metrics

Metric
Days Sales Outstanding2.03
Days Payables Outstanding21.21
Days Inventory Outstanding48.94
Operating Cycle97.37
Cash Conversion Cycle62.09
Asset Turnover0.56

Cash Flow Metrics

Metric
Operating Cash Flow-155.53M
Free Cash Flow-165.19M
Cash Flow to Debt-1.75
Operating Cash Flow/Sales-0.65
Free Cash Flow Yield-0.50

Balance Sheet Metrics

Metric
Cash & Equivalents217.89M
Accounts Receivable-1.43M
Inventory12.46M
Goodwill
Debt to Capitalization0.34
Debt to Assets0.10
Current Ratio2.93
Quick Ratio1.87

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.49
R&D to Revenue0.87
SG&A to Revenue0.53